204 related articles for article (PubMed ID: 26823840)
41. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism].
Zhang D; Liu CT; Yu XD; Liu Y
Ai Zheng; 2009 Dec; 28(12):1270-6. PubMed ID: 19958621
[TBL] [Abstract][Full Text] [Related]
42. p53 in trichostatin A induced C6 glioma cell death.
Hsu YF; Sheu JR; Hsiao G; Lin CH; Chang TH; Chiu PT; Wang CY; Hsu MJ
Biochim Biophys Acta; 2011 May; 1810(5):504-13. PubMed ID: 21376104
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
[TBL] [Abstract][Full Text] [Related]
44. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
45. Hyper-acetylation contributes to the sensitivity of chemo-resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A.
Xu Q; Liu X; Zhu S; Hu X; Niu H; Zhang X; Zhu D; Nesa EU; Tian K; Yuan H
J Cell Mol Med; 2018 Mar; 22(3):1909-1922. PubMed ID: 29327812
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
Duncan HF; Smith AJ; Fleming GJ; Cooper PR
J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
[TBL] [Abstract][Full Text] [Related]
47. Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1.
D'Acunto CW; Fontanella B; Rodriquez M; Taddei M; Parente L; Petrella A
Cancer Lett; 2010 Sep; 295(1):85-91. PubMed ID: 20227822
[TBL] [Abstract][Full Text] [Related]
48. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of trichostatin A on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT-20 cells.
Nakada Y; Kageyama K; Sugiyama A; Desaki R; Takayasu S; Niioka K; Murasawa S; Ishigame N; Asari Y; Iwasaki Y; Daimon M
Endocr J; 2015; 62(12):1083-90. PubMed ID: 26497760
[TBL] [Abstract][Full Text] [Related]
50. Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells.
Dowdy SC; Jiang S; Zhou XC; Hou X; Jin F; Podratz KC; Jiang SW
Mol Cancer Ther; 2006 Nov; 5(11):2767-76. PubMed ID: 17121923
[TBL] [Abstract][Full Text] [Related]
51. Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.
Gameiro SR; Malamas AS; Tsang KY; Ferrone S; Hodge JW
Oncotarget; 2016 Feb; 7(7):7390-402. PubMed ID: 26862729
[TBL] [Abstract][Full Text] [Related]
52. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
53. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
[TBL] [Abstract][Full Text] [Related]
54. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
[TBL] [Abstract][Full Text] [Related]
55. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
[TBL] [Abstract][Full Text] [Related]
57. The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.
Vallo S; Mani J; Stastny M; Makarević J; Juengel E; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
Invest New Drugs; 2013 Apr; 31(2):265-72. PubMed ID: 22801803
[TBL] [Abstract][Full Text] [Related]
58. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
59. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2007 Oct; 142(2):219-26. PubMed ID: 17612559
[TBL] [Abstract][Full Text] [Related]
60. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
